(215 ILCS 5/126.29)
Sec. 126.29.
Securities lending and repurchase, reverse repurchase, and
dollar roll transactions. An insurer may enter into securities lending,
repurchase, reverse repurchase, and dollar roll transactions with business
entities, subject to the following requirements:
A. The insurer's board of directors shall adopt a written plan that is
consistent with the requirements of the written plan in Section 126.4A that
specifies guidelines and objectives to be followed, such as:
(1) A description of how cash received will be invested or used for general corporate |
|
(2) Operational procedures to manage interest rate risk, counterparty default risk, the
|
| conditions under which proceeds from reverse repurchase transactions may be used in the ordinary course of business and the use of acceptable collateral in a manner that reflects the liquidity needs of the transaction; and
|
|
(3) The extent to which the insurer may engage in these transactions.
B. The insurer shall enter into a written agreement for all transactions
authorized in this Section other than dollar roll transactions. The written
agreement shall require that each transaction terminate no more than one year
from its inception or upon the earlier demand of the insurer. The agreement
shall be with the business entity counterparty, but for securities lending
transactions, the agreement may be with an agent acting on behalf of the
insurer, if the agent is a qualified business entity, and if the agreement:
(1) Requires the agent to enter into separate agreements with each counterparty that are
|
| consistent with the requirements of this Section; and
|
|
(2) Prohibits securities lending transactions pursuant to the agreement with the agent
|
|
C. Cash received in a transaction under this Section shall be invested in
accordance with this Article and in a manner that recognizes the liquidity
needs of the transaction or used by the insurer for its general corporate
purposes. For so long as the transaction remains outstanding, the insurer, its
agent or custodian shall maintain, as to acceptable collateral received in a
transaction under this Section, either physically or through the book entry
systems of the Federal Reserve, Depository Trust Company, Participants Trust
Company or other securities depositories approved by the Director:
(1) Possession of the acceptable collateral;
(2) A perfected security interest in the acceptable collateral; or
(3) In the case of a jurisdiction outside of the United States, title to, or rights of a
|
| secured creditor to, the acceptable collateral.
|
|
D. The limitations of Sections 126.23 and 126.30 shall not apply to the
business entity
counterparty exposure created by transactions under this Section. For purposes
of calculations made to determine compliance with this subsection, no effect
will
be given to the insurer's future obligation to resell securities, in the case
of a repurchase transaction, or to repurchase securities, in the case of a
reverse repurchase transaction. An insurer shall not enter into a transaction
under this Section if, as a result of and after giving effect to the
transaction:
(1) The aggregate amount of securities then loaned or sold to, or purchased from, any
|
| one business entity counterparty under this Section would exceed 5% of its admitted assets. In calculating the amount sold to or purchased from a business entity counterparty under repurchase or reverse repurchase transactions, effect may be given to netting provisions under a master written agreement; or
|
|
(2) The aggregate amount of all securities then loaned, sold to or purchased from all
|
| business entities under this Section would exceed 40% of its admitted assets but the limitation of this subsection shall not apply to reverse repurchase transactions for so long as the borrowing is used to meet operational liquidity requirements resulting from an officially declared catastrophe and subject to a plan approved by the Director.
|
|
E. In a dollar roll transaction, the insurer shall receive cash in an amount
at least equal to the market value of the securities transferred by the insurer
in the transaction as of the transaction date.
F. The Director may promulgate reasonable rules for investments
and transactions under this Section including, but not limited to, rules
which impose financial solvency standards, valuation standards, and
reporting requirements.
(Source: P.A. 90-418, eff. 8-15-97.)
|